EU: Antibiotics - Market Report. Analysis And Forecast To 2025
This report focuses on the EU antibiotic market, providing a comprehensive analysis and the most recent data on its market size and volume, EU trade, price dynamics, domestic production, and turnover in the industry. The market trends section reveals the main issues and uncertainties concerning the industry, while the medium-term outlook uncovers market prospects. The attractivity index (IB Index) summarizes the source of existing opportunities as they appear in this market, as well as an interpretation of the trade figures.
EU(28) - Austria, Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Croatia, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden, the United Kingdom.
Penicillin and their derivatives with a penicillin acid structure, streptomycin and their derivatives, tetracycline and their derivatives, chloramphenicol and its derivatives, erythromycin and its derivatives and other antibiotics and salts thereof of all the above. These products should be understood as organic compounds (they belong to HS chapter 29), not ready to be used as pharmaceutical products/medicaments. In this sense, the products making up the code 35250-3 are distinct from medicaments containing them.